The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm
- PMID: 31792646
- PMCID: PMC7024045
- DOI: 10.1007/s00213-019-05392-z
The influence of gender and oxytocin on stress reactivity, cigarette craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm
Abstract
Rationale: Female cigarette smokers tend to show greater cessation failure compared with males. Variables that contribute to the maintenance of smoking, including stress and craving, may differentially impact male and female smokers. Novel pharmacotherapies, such as oxytocin, may attenuate stress reactivity and craving in smokers, but work in this area is limited.
Objectives: This study assessed the influence of gender and oxytocin on stress reactivity, craving, and smoking in a randomized, placebo-controlled laboratory relapse paradigm.
Methods: Male and female adult cigarette smokers (ages 18-45) were enrolled (women oversampled 2:1) and completed a laboratory session, in which intranasal oxytocin or placebo was administered followed by a laboratory social stress task. The role of gender and oxytocin were assessed on measures of stress reactivity, cigarette craving, latency to smoke in a resistance task, subjective responses to smoking, and ad-libitum smoking.
Results: Participants (N = 144) had a mean age of 31 were 63% female and 56% White. Following stress induction, female smokers evidenced greater subjective stress than males, though males demonstrated greater neuroendocrine reactivity and smoking intensity than females. No gender differences were demonstrated for craving. Oxytocin did not attenuate any aspect of stress reactivity, craving, smoking, or subjective responses to smoking compared with placebo.
Conclusions: Gender differences in stress reactivity were shown in the hypothesized direction, but oxytocin appeared to exert little impact on subjective or behavioral metrics. Results highlight the complex relationship between gender, stress, and smoking, as well as the implications for oxytocin as a potential pharmacotherapy for smoking cessation.
Keywords: Cortisol; Craving; Cue reactivity; Gender; Oxytocin; Relapse; Sex; Smoking; Stress.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7024045/bin/nihms-1544982-f0001.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7024045/bin/nihms-1544982-f0002.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7024045/bin/nihms-1544982-f0003.gif)
![Figure 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7024045/bin/nihms-1544982-f0004.gif)
Similar articles
-
Effects of Ovarian Hormone Levels on Stress, Cigarette Craving, and Smoking in a Laboratory Relapse Paradigm Among Females Who Smoke Daily.Nicotine Tob Res. 2024 Feb 22;26(3):392-396. doi: 10.1093/ntr/ntad132. Nicotine Tob Res. 2024. PMID: 37493638 Free PMC article.
-
Effects of Intranasal Oxytocin on Stress-Induced Cigarette Craving in Daily Smokers.Nicotine Tob Res. 2020 Jan 27;22(1):89-95. doi: 10.1093/ntr/nty159. Nicotine Tob Res. 2020. PMID: 30085292 Free PMC article. Clinical Trial.
-
Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.J Stud Alcohol Drugs. 2018 Nov;79(6):918-928. doi: 10.15288/jsad.2018.79.918. J Stud Alcohol Drugs. 2018. PMID: 30573023 Free PMC article.
-
Can intranasal oxytocin reduce craving in automated addictive behaviours? A systematic review.Br J Pharmacol. 2021 Nov;178(21):4316-4334. doi: 10.1111/bph.15617. Epub 2021 Aug 31. Br J Pharmacol. 2021. PMID: 34235724 Review.
-
Cue-reactivity targeted smoking cessation intervention in individuals with tobacco use disorder: a scoping review.Front Psychiatry. 2023 Sep 7;14:1167283. doi: 10.3389/fpsyt.2023.1167283. eCollection 2023. Front Psychiatry. 2023. PMID: 37743997 Free PMC article. Review.
Cited by
-
Methylation of the Oxytocin, Oxytocin Receptor, and Vasopressin Gene Promoters in Tobacco Use Disorder during Cessation.Neuropsychobiology. 2024;83(1):28-40. doi: 10.1159/000535663. Epub 2024 Jan 5. Neuropsychobiology. 2024. PMID: 38185116 Free PMC article.
-
Effects of Ovarian Hormone Levels on Stress, Cigarette Craving, and Smoking in a Laboratory Relapse Paradigm Among Females Who Smoke Daily.Nicotine Tob Res. 2024 Feb 22;26(3):392-396. doi: 10.1093/ntr/ntad132. Nicotine Tob Res. 2024. PMID: 37493638 Free PMC article.
-
Differential prevalence of Adverse Childhood Experiences (ACEs) by gender and substance used in individuals with cannabis, cocaine, opioid, and tobacco use disorders.Am J Drug Alcohol Abuse. 2023 Mar 4;49(2):190-198. doi: 10.1080/00952990.2023.2171301. Epub 2023 Mar 7. Am J Drug Alcohol Abuse. 2023. PMID: 36881810 Free PMC article.
-
Sex and drug differences in stress, craving and cortisol response to the trier social stress task.Psychopharmacology (Berl). 2022 Sep;239(9):2819-2827. doi: 10.1007/s00213-022-06163-z. Epub 2022 May 20. Psychopharmacology (Berl). 2022. PMID: 35589850
-
Affective mechanisms of stress-induced cigarette craving: Considerations of gender and race/ethnicity.Addict Behav. 2022 Jul;130:107293. doi: 10.1016/j.addbeh.2022.107293. Epub 2022 Feb 23. Addict Behav. 2022. PMID: 35220151 Free PMC article.
References
-
- al’Absi M, Nakajima M, Allen S, Lemieux A, Hatsukami D (2015) Sex differences in hormonal responses to stress and smoking relapse: a prospective examination Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 17:382–389 doi:10.1093/ntr/ntu340 - DOI - PMC - PubMed
-
- Baer JS, Kamarck T, Lichtenstein E, Ransom CC Jr, (1989) Prediction of smoking relapse: analyses of temptations and transgressions after initial cessation J Consult Clin Psychol 57:623–627 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U54 DA016511/DA/NIDA NIH HHS/United States
- K01DA036739/DA/NIDA NIH HHS/United States
- R01DA042114/DA/NIDA NIH HHS/United States
- U01DA031779/DA/NIDA NIH HHS/United States
- T32DA035200/DA/NIDA NIH HHS/United States
- R25 DA020537/DA/NIDA NIH HHS/United States
- K12 HD055885/HD/NICHD NIH HHS/United States
- U01 DA031779/DA/NIDA NIH HHS/United States
- UL1 TR001450/TR/NCATS NIH HHS/United States
- K01 DA036739/DA/NIDA NIH HHS/United States
- P50DA016511/DA/NIDA NIH HHS/United States
- T32 DA035200/DA/NIDA NIH HHS/United States
- R01 DA042114/DA/NIDA NIH HHS/United States
- P50 DA016511/DA/NIDA NIH HHS/United States
- UL1TR001450/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical